Stocks · Health care · Pharmaceutical Preparations

Regeneron Pharmaceuticals

REGN Clue Score51
United States Fiscal year ends December CIK 0000872589 Results filed 30 Oct 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Christopher R. Fenimore
2 Nov 2026
EVP Finance CFO
Exercised, kept
6,000
$381.92
$2.29M
Andrew J Murphy
13 Oct 2026
Co-Chief Scientific Officer
Exercised, kept
17,000
$381.92
$6.49M

What was left out

Form 4 filings counted 10
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 28
Sales straight out of an exercise 21
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 95,001
History held since 3 Oct 2006